Announcing the launch of the newly rebranded ECHO Program and the opening of applications for the 2025-2026 cohort!
Now led by the Temerty Faculty of Medicine and supported through a strategic partnership with the Translational Biology and Engineering Program at the Ted Rogers Centre for Heart Research, ECHO preserves its strong cardiovascular foundation while expanding its support to innovators across all health disciplines.
What Is Offered:
ECHO is a 12-month national training program that provides entrepreneurship training, mentorship, partnership and funding opportunities (up to $100K) for early ventures in the health sector. The program is comprised of five complementary modules, delivered by veteran entrepreneurs and consultants across a variety of sectors.
To reach teams across Canada, ECHO is a fully virtual program.
Who is Eligible?
Applicants may apply through one of two distinct streams:
- Cardiovascular Stream: Open to Canada-based researchers, scientists, clinicians, trainees or entrepreneurs developing cardiovascular technologies.
- General Health Stream: Open to researchers, scientists and trainees developing health technologies outside the cardiovascular field. Applicants must either hold a primary appointment at the Temerty Faculty of Medicine or be supervised by a faculty member with a primary appointment at Temerty Medicine. While this stream is initially limited to Temerty-affiliated applicants, the program will explore expanding eligibility through future partnerships.
Application:
Complete the following two forms and submit by 11:59 pm ET on Sunday, August 17, 2025.
1. ECHO Application Form: submit to Soror Sharifpoor
2. H2i Venture Application Form: submit online
Interviews: Interviews will commence September 2025 for select applicants. The program begins October 2025.
For full program information and enrolment instructions, please visit the ECHO program page or contact Soror Sharifpoor (Director, Commercialization & Partnership, Temerty Faculty of Medicine)
Led by the Temerty Faculty of Medicine at the University of Toronto, the ECHO program relaunch is made possible through a partnership with the Translational Biology & Engineering Program (TBEP) at the Ted Rogers Centre for Heart Research and with support from the Health Innovation Hub (H2i), Temerty Medicine’s health accelerator.